An interventional study of remifentanil and nitroprusside in Hypotension, Controlled, sponsored by Jeju National University School of Medicine. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2013-12-04.
Sponsored by Jeju National University School of Medicine · Not applicable and Interventional
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 38 studies in Hypotension with a site in Korea, Republic of — 4 open to participants now, 4 under way, none of them phase 3. Hypotension · Korea, Republic of.
Among the 38 studies in Hypotension with a site in Korea, Republic of, this one is the 25th largest by enrollment of the 27 interventional ones that give a count, is one of 3 that started in 2012, is one of 23 with no phase, and was the 7th registered.
892 studies on the registry are indexed under Hypotension; 199 are open to participants now.
Browse Hypotension studies →4 of the 38 studies in Hypotension with a site in Korea, Republic of are open now. Recruiting first, the newest first:
Seoul National University Hospital · Sites in Korea, Republic of
Ages 19+ · Women only · Healthy volunteers
Samsung Medical Center · Sites in Korea, Republic of
Ages 19+
Sky Labs · Sites in Korea, Republic of
Ages 18–80 · Healthy volunteers
Seoul National University Hospital · Sites in Korea, Republic of
Ages 19+
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 114 Hypotension studies recruiting now, 53 (46%) set no upper age limit and 36 (32%) stop at 75 or younger; 7 take children under 18; 16 take healthy volunteers.
This study: 20 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
38 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 3 started in 2012.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 30 is below the median of 86 across 593 interventional studies indexed under Hypotension.
Median enrollment 87 across the 27 interventional studies, 80 across the 11 observational. Of the 24 that completed or were terminated, 4 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 38 have an industry lead sponsor. The 10 most frequent:
Jeju National University School of Medicine is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
Jeju National University School of Medicine has 1 study filed under Hypotension — fewer than ten, so there is no comparison to draw.
1 of the studies in Hypotension with a site in Korea, Republic of that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07324512Seoul National University HospitalMinimum Effective Volume of Crystalloid Co-Loading to Prevent Spinal Anesthesia-Induced Hypotension in Cesarean Section | 2027-05-31 |
Add it to your calendar (.ics) → With an account.
Among the 38 studies in Hypotension with a site in Korea, Republic of, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is the comparison of the cardiovascular effects of remifentanil and nitroprusside for controlled hypotension
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
After induction of anesthesia, controlled hypotension was induced with continuous infusion of nitroprusside. Cardiac index, stroke volume index, and total peripheral resistance index were continuously measured using noninvasive cardiac output monitor (Cheetah NICOM, Cheetah Medical Inc, UK).
Drug: nitroprusside
After induction of anesthesia, controlled hypotension was induced with continuous infusion of remifentanil. Cardiac index, stroke volume index, and total peripheral resistance index were continuously measured using noninvasive cardiac output monitor (Cheetah NICOM, Cheetah Medical Inc, UK).
Drug: remifentanil
Cardiac index
Cardiac index was continuously measured during controlled hypotension using noninvasive cardiac output monitor. The average of cardiac index during controlled hypotension was compared with baseline value.
Time frame: Cardiac index was continuously measured during controlled hypotension, an average of 90 min
Total peripheral resistance index
Total peripheral resistance index was continuously measured during controlled hypotension using noninvasive cardiac output monitor. The average of total peripheral resistance index during controlled hypotension was compared with baseline value.
Time frame: Total peripheral resistance index was continuously measured during controlled hypotension, an average of 90 min
Stroke volume index
Stroke volume index was continuously measured during controlled hypotension using noninvasive cardiac output monitor. The average of stroke volume index during controlled hypotension was compared with baseline value.
Time frame: Stroke volume index was continuously measured during controlled hypotension, an average of 90 min
The record gives a start of Jun 2012 and a primary completion of Jul 2013. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Remifentanil · Nitroprusside
Jeju National University School of Medicine